Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 31, 2019Venetoclax Resistance: Mechanisms and Treatment Options - Matthew S. Davids, MD, MMScPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease21 minPlay
December 31, 2019Update on CAR-T Cells in CLL - Thomas J. Kipps, MD, PhDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease25 minPlay
December 31, 2019NOTCH1: The Clinical and Basic Science Behind it - Silvia Deaglio, MD, PhDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease14 minPlay
December 31, 2019Treatment for BTKi Progressors - Richard R. Furman, MDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease21 minPlay
December 31, 2019Richter's: Who will Get, What to Do? - Jennifer R. Brown, MD, PhDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease20 minPlay
December 31, 2019Panel Discussion: Next Line Treatment in CLL - Neil E. Kay, MDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease11 minPlay
December 31, 2019Immune Function in CLL: What is Wrong and Why? - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease31 minPlay
December 31, 2019CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MDPositioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease49 minPlay
December 31, 2019What is New in WM? How I Treat it - Steven P. Treon, MD, PhD, FACP, FRCPUnderstanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Therapies25 minPlay
December 31, 2019WM Case Discussions - Richard R. Furman, MD and Steven P. Treon, MD, PhD, FACP, FRCPUnderstanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Therapies31 minPlay